摘要
细胞周期蛋白依赖性激酶 (CDK) 包括约 20 种丝氨酸/苏氨酸激酶家族,其催化活性需要称为细胞周期蛋白的调节亚基;这些酶在细胞周期和转录中发挥多种作用。 PCTAIRE 激酶 (PCTK) 是 CDK 亚家族,其特征在于共有 PSTAIRE 基序中的丝氨酸至半胱氨酸突变,参与与细胞周期蛋白的结合。该类的一个成员是 PCTK3,它有两个同种型(a 和 b),也称为 CDK18。在被细胞周期蛋白 A2 激活或被 PKA 磷酸化 Ser12 后,PCTK3 可以执行多种功能。在这些功能中,我们可以强调以下内容:膜运输中货物运输的调节、p53 响应基因、基因组完整性的调节。根据不同的研究,PCTK3功能障碍与多种疾病有关,如代谢性疾病、脑缺血、抑郁症、癌症、神经系统疾病和阿尔茨海默病等。尽管该蛋白质参与了不同的生物学事件,但我们可以说 PCTK3 受到的关注远低于其他 CDK。关于其他 CDK 的已发表文章数以千计,与 PCTK3 相关的文章不足两百篇。本综述的主要目的是介绍有关该蛋白质的选定已发表研究。与其他 CDK 相比,我们的重点是 PCTK3 的特殊性。在这里,我们概述了 PCTK3 的生物学功能,并探索其作为药物设计靶点的潜力。
关键词: CDK18、PCTAIRE 3、DNA 复制应激、转录、癌症、阿尔茨海默病、PCTK3。
Current Medicinal Chemistry
Title:Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells
Volume: 28 Issue: 33
关键词: CDK18、PCTAIRE 3、DNA 复制应激、转录、癌症、阿尔茨海默病、PCTK3。
摘要: Cyclin-dependent kinases (CDKs) comprise a family of about 20 serine/threonine kinases whose catalytic activity requires a regulatory subunit known as cyclin; these enzymes play several roles in the cell cycle and transcription. PCTAIRE kinases (PCTKs) are a CDK subfamily, characterized by serine to cysteine mutation in the consensus PSTAIRE motif, involved in binding to the cyclin. One member of this class is PCTK3, which has two isoforms (a and b) and is also known as CDK18. After being activated by cyclin A2 or phosphorylation at Ser12 by PKA, PCTK3 can perform several functions. Among these functions, we may highlight the following: modulation of cargo transport in membrane traffic, p53-responsive gene, regulation of genome integrity. According to different studies, PCTK3 dysfunction is related to a wide range of diseases, such as metabolic diseases, cerebral ischemia, depression, cancer, neurological disorders, and Alzheimer's disease. Although this protein participates in different biological events, we may say that PCTK3 has received far less attention than other CDKs. There are thousands of published articles about other CDKs and less than two hundred articles related to PCTK3. The main objective of this review is to present the selected published studies about this protein. Our focus is on PCTK3 particularities compared to other CDKs. Here we give an overview of the biological functions of PCTK3 and explore its potential as a target for drug design.
Export Options
About this article
Cite this article as:
Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells, Current Medicinal Chemistry 2021; 28 (33) . https://dx.doi.org/10.2174/0929867328666210329122147
DOI https://dx.doi.org/10.2174/0929867328666210329122147 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potent Non-Peptide Thrombin Receptor Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Peptide Targeted Copper-64 Radiopharmaceuticals
Current Topics in Medicinal Chemistry Proteasome Inhibitors and Modulators of Angiogenesis in Multiple Myeloma
Current Medicinal Chemistry Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Advances in Drug Discovery and Development for Pediatric Tuberculosis
Mini-Reviews in Medicinal Chemistry Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy
Current Pharmaceutical Design Status of Non-Classical Mononuclear Platinum Anticancer Drug Development
Mini-Reviews in Medicinal Chemistry Statistical Analysis, Optimization, and Prioritization of Virtual Screening Parameters for Zinc Enzymes Including the Anthrax Toxin Lethal Factor
Current Topics in Medicinal Chemistry Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry Improved Pharmacokinetic Profile and Anti-Inflammatory Property of a Novel Curcumin Derivative, A50
Letters in Drug Design & Discovery Progress in Understanding Basal Ganglia Dysfunction as a Common Target for Methamphetamine Abuse and HIV-1 Neurodegeneration
Current HIV Research Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry CYP2A5 Induction and Hepatocellular Stress: An Adaptive Response to Perturbations of Heme Homeostasis
Current Drug Metabolism Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective Effects of Ellagitannins: A Brief Review
Current Drug Targets Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer
Current Pharmaceutical Design Emerging Therapeutic Approaches Multi-Targeting Receptor Tyrosine Kinases and G Protein-Coupled Receptors in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Metabolism of Rhaponticin and Activities of its Metabolite, Rhapontigenin: A Review
Current Medicinal Chemistry Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry